title: Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms.
abstract: There is strong evidence that catechol-O-methyl transferase (COMT) protects breast cells against estrogen-induced cancer by detoxifying catecholestrogens, the carcinogenic estrogen metabolites. COMT gene expression is controlled by two promoters - a proximal promoter (COMTP1) and a distal promoter (COMTP2) - that regulate the expression of soluble (S-COMT) and membrane-bound (MB-COMT) isoforms, respectively. We investigated the transcriptional regulation of the COMT gene by progesterone/progesterone receptors in breast cancer cells. Our results indicated that progesterone (P4) downregulates COMT gene expression in breast cancer cell lines. In addition, the COMTP1 and COMTP2 harbor several progesterone response elements (PREs). Electrophoretic mobility shift assay (EMSA) indicated that nuclear extracts of T47D cells bind to the identified PREs in COMTP1. Site-directed mutagenesis of PREs in COMTP1 not only reversed the P4-induced inhibition of COMTP1, but also increased its basal activity. The two progesterone receptor isoforms, PR-A and PR-B, were found to have opposite effects on the regulation of P4 in COMT expression; PR-A is associated with P4-induced upregulation of COMT, while PR-B is associated with P4-induced downregulation of COMT. In summary, our data demonstrated that P4 downregulates the COMT gene expression through multiple PREs in the COMT promoters and that different progesterone receptor isoforms have distinctive effects on COMT gene expression.
authors: Department of Obstetrics and Gynecology, 301 University Blvd., University of Texas Medical Branch, Galveston, TX 77555-1066, USA. sasalama@utmb.edu
authors: Salama A
authors: SA
authors: Salama
authors: Mohammad
authors: M
authors: Jamaluddin
authors: Raj
authors: R
authors: Kumar
authors: Memy H
authors: MH
authors: Hassan
authors: Ayman
authors: A
authors: Al-Hendy
mesh_terms: D001483:Base Sequence; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D045744:Cell Line, Tumor; D017931:DNA Primers; D015536:Down-Regulation; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D006801:Humans; D011374:Progesterone / Q000494:pharmacology*; D020033:Protein Isoforms / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D020033:Protein Isoforms; D012333:RNA, Messenger; D011980:Receptors, Progesterone; D011374:Progesterone; D002394:Catechol O-Methyltransferase
references: J Biol Chem. 2002 Feb 15;277(7):5209-18
references: 11717311
references: Int J Oncol. 2003 Mar;22(3):499-508
references: 12579301
references: Lancet. 2003 Aug 9;362(9382):419-27
references: 12927427
references: Neuropharmacology. 2003 Dec;45(7):1011-8
references: 14573393
references: J Mammary Gland Biol Neoplasia. 2003 Jul;8(3):257-68
references: 14973372
references: Cell Mol Life Sci. 2004 May;61(9):1114-22
references: 15112058
references: J Steroid Biochem. 1986 Jan;24(1):353-6
references: 3009986
references: Fed Proc. 1987 Apr;46(5):1858-63
references: 3030825
references: Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1416-20
references: 1847521
references: Mol Endocrinol. 1993 Oct;7(10):1244-55
references: 8264658
references: Eur J Biochem. 1994 Aug 1;223(3):1049-59
references: 8055944
references: Hum Gene Ther. 1995 Feb;6(2):165-75
references: 7734517
references: Biochim Biophys Acta. 1995 Aug 16;1251(1):1-10
references: 7647086
references: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9776-81
references: 8790407
references: Chem Res Toxicol. 1996 Jul-Aug;9(5):851-9
references: 8828920
references: Eur J Biochem. 1997 Jan 15;243(1-2):452-9
references: 9030772
references: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42
references: 9380738
references: Cancer Res. 1997 Dec 15;57(24):5493-7
references: 9407957
references: Carcinogenesis. 1998 Jan;19(1):1-27
references: 9472688
references: Cancer Res. 1998 Jun 1;58(11):2269-77
references: 9622057
references: Mol Pharmacol. 1999 Jul;56(1):31-8
references: 10385681
references: Cancer Lett. 1999 Sep 20;144(1):75-84
references: 10503880
references: Mol Endocrinol. 2005 Mar;19(3):574-87
references: 15563544
references: J Natl Cancer Inst. 2005 May 18;97(10):755-65
references: 15900045
references: Ann N Y Acad Sci. 2005 Jun;1052:243-57
references: 16024767
references: Cancer Detect Prev. 2005;29(5):427-32
references: 16191465
references: Climacteric. 2005 Dec;8(4):311-6
references: 16390765
references: Mol Cell Endocrinol. 2006 Mar 9;247(1-2):116-26
references: 16442706
references: Fertil Steril. 2006 Jul;86(1):259-62
references: 16730007
references: Biochim Biophys Acta. 2006 Aug;1766(1):63-78
references: 16675129
references: Mol Endocrinol. 2006 Oct;20(10):2278-91
references: 16740655
references: Pharmacol Rev. 1999 Dec;51(4):593-628
references: 10581325
references: JAMA. 2000 Jan 26;283(4):485-91
references: 10659874
references: J Natl Cancer Inst. 2000 Feb 16;92(4):328-32
references: 10675382
references: Mol Cell Biol. 2000 May;20(9):3102-15
references: 10757795
references: J Natl Cancer Inst Monogr. 2000;(27):67-73
references: 10963620
references: J Natl Cancer Inst Monogr. 2000;(27):75-93
references: 10963621
references: Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):209-16
references: 11303589
references: Physiol Rev. 2001 Jul;81(3):1269-304
references: 11427696
references: Mol Endocrinol. 2001 Dec;15(12):2078-92
references: 11731610
references: Oncogene. 2001 Nov 29;20(55):7945-53
references: 11753677